<code id='FC1AE66F91'></code><style id='FC1AE66F91'></style>
    • <acronym id='FC1AE66F91'></acronym>
      <center id='FC1AE66F91'><center id='FC1AE66F91'><tfoot id='FC1AE66F91'></tfoot></center><abbr id='FC1AE66F91'><dir id='FC1AE66F91'><tfoot id='FC1AE66F91'></tfoot><noframes id='FC1AE66F91'>

    • <optgroup id='FC1AE66F91'><strike id='FC1AE66F91'><sup id='FC1AE66F91'></sup></strike><code id='FC1AE66F91'></code></optgroup>
        1. <b id='FC1AE66F91'><label id='FC1AE66F91'><select id='FC1AE66F91'><dt id='FC1AE66F91'><span id='FC1AE66F91'></span></dt></select></label></b><u id='FC1AE66F91'></u>
          <i id='FC1AE66F91'><strike id='FC1AE66F91'><tt id='FC1AE66F91'><pre id='FC1AE66F91'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:comprehensive    Page View:16453
          Gilead office remdesivir
          Yichuan Cao/Sipa USA

          Gilead Sciences said Monday it will acquire CymaBay Therapeutics for $4.3 billion, adding a new treatment for a liver disease that is on track for approval later this year.

          The deal values CymaBay at $32.50 per share, 27% higher than the stock’s close last Friday. That’s a relatively small takeout premium, but CymaBay shares have doubled in value since last fall on growing investor confidence in the company’s lead drug and speculation that the company could be acquired.

          advertisement

          CymaBay’s drug, called seladelpar, is being developed for the treatment of primary biliary cholangitis, or PBC, a type of liver disease mainly affecting women that causes decreased liver function, and debilitating itching and fatigue. Progression of PBC to more advanced stages increases the risk of liver-related death.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          Wikipedia

          Novavax promises a turnaround & Lilly roils the obesity market
          Novavax promises a turnaround & Lilly roils the obesity market

          SammyKimballforSTATCanNovavaxfinallygetitright?What’sa“triple-G”drug?AndisNovoNordisklosingground?We

          read more
          What Henrietta Lacks's story taught me about my role as a doctor
          What Henrietta Lacks's story taught me about my role as a doctor

          MikeReddyforSTATWhenIwasinmedicalschool,duringmyOB-GYNrotation,oneofmyclassmatessaidtome,“Somepeople

          read more
          Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen
          Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

          1:19Ademonstratorrunsonthethirdnightofprotestssparkedbythefatalpoliceshootingofa17-year-olddriverint

          read more

          FDA approves first blood sugar monitor without finger pricks

          TheFDAhasapprovedadevicefromAbbottthatcontinuouslymonitorsdiabetics’bloodsugarlevelswithoutrequiring